U.S. Bancorp enters the back half of 2026 with a clean earnings beat behind it and a Wall Street that just spent two weeks resetting its price targets higher — yet the stock at $64.43 still trades at a meaningful discount to where most analysts think it belongs.
The analyst reaction to Q2 results tells the clearest story here. The direction of travel is unambiguously positive. Evercore ISI upgraded USB to Outperform and raised its target from $65 to $72 on July 20. JP Morgan's Vivek Juneja moved from Underweight to Neutral the same day, lifting his target to $67.50. The following day a cluster of firms — Oppenheimer, Wells Fargo, Truist, RBC, DA Davidson, and KBW — all raised targets, citing stronger net interest margins and improving credit quality. Today, JP Morgan raised again, nudging the target to $69. The Street's mean target now sits at $70.32, implying roughly 9% upside from current levels. The consensus leans constructive, even if most firms still stop short of outright Buy ratings. The bear case centers on Midwest/West concentration risk and questions about whether revenue growth can be sustained without relying on further acquisitions.
Valuation multiples reflect the re-rating in progress. The price-to-earnings multiple has expanded by close to 0.2 points over the past 30 days to just under 11.6x, and price-to-book has moved up by roughly 0.07 to 1.53x over the same period. Neither multiple is stretched for a diversified bank, which explains the bull case: at 11.6x earnings, there is room for further re-rating if USB continues to deliver on margin and credit quality. Factor scores support the positive framing — EPS momentum ranks in the 81st percentile on a 30-day basis and 74th on 90 days, while analyst recommendation momentum ranks in the top 1% of the universe at the 99th percentile.
Short interest is low but worth noting for its recent direction. At 1.66% of free float, there is nothing aggressive here — this is not a heavily shorted name. What is modestly interesting is that shorts rebuilt about 11% in the space of a week, adding roughly 2.4 million shares between July 21 and July 24. That move coincided with the post-earnings analyst upgrades, suggesting some hedging activity rather than outright bearish conviction. The borrow market is essentially frictionless: availability is at its maximum reading and cost to borrow is just 0.41%, down slightly on the week. There is no squeeze pressure and no sign that the short-side activity is anything more than tactical.
Options positioning has tilted mildly bullish. The put/call ratio has drifted below its 20-day average, running at 0.64 against a mean of 0.68 — about one standard deviation below trend. That is not an extreme reading, but it points toward more call activity relative to puts, consistent with the positive analyst tone following earnings. The PCR has been trending lower since mid-June when it was running above 0.85, and this week's two-day close near the lower end of the 52-week range of 0.56–1.19 supports the view that near-term sentiment has shifted.
Insider activity over the past 90 days is net selling — roughly $5.7 million in aggregate — but this is consistent with the pattern at large financials where executive compensation plans generate regular sales around earnings periods. The General Counsel sold $1.45 million worth of stock on July 23, and the Non-Executive Vice Chairman sold $2.33 million on July 20 at $63.08. Neither trade carries unusual significance, and the net 94,000-share figure is a rounding error relative to the 1.56 billion share float. Among institutional holders, JP Morgan Asset Management added over 13.6 million shares in the quarter to June 30, making it the most active buyer among the top fifteen holders.
On the peer front, USB's 1.1% weekly gain compares reasonably with PNC (+0.5%), Fifth Third (+0.2%), and Citizens Financial (+1.3%), though Huntington Bancshares dropped 4.8% on the week and KeyCorp fell 1.4%, pointing to some dispersion across the regional bank cohort after earnings season. USB's relative firmness reflects the cleaner Q2 print and the upgrade cycle that followed it.
Next quarter's earnings are scheduled for October 15. Between now and then, the data to watch is net interest margin guidance versus realised outcomes and whether provision for credit losses ticks back up — the two variables the bear case is built on.
See the live data behind this article on ORTEX.
Open USB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
